View more job listings or post a job
Revolution Medicines Senior Scientist, DMPK and Clinical Pharmacology
Quintara Discovery Research Scientist (Bioanalysis)
Quintara Discovery Research Scientist (Bioanalysis)
Chinook Therapeutics, Inc Sr. Scientist, In Vivo Pharmacology (Team Lead)
AbVision Senior/Principle Scientist (Immunology/Cell Biology)
Genentech, Inc. Associate Scientist, Biomarker Mass Spectrometry Laboratory  
Genentech, Inc. Senior Scientific Researcher for Biomarker Mass Spectrometry Laboratory
Genentech Inc. Contractor Scientist–Drug Metabolism
Genentech, Inc. Associate Scientist / Scientist, Biotransformation and ADME of New Modality  
Genentech, Inc. Scientist / Sr. Scientist, Drug Metabolism and Pharmacokinetics  
Post a job


In Vitro Diagnostics (IVD) & Companion Diagnostics (CDx): Guiding Clinical Trials and Patient Treatment through Precision Medicine

Speakers: Eric Fung (GRAIL), Sharon Pitteri (Stanford), Hua-Fen Liu (Dian Diagnistics), Chris Apfel (Sage Medic), Sean Zhang (Johns Hopkins), Kunbin Qu (Beigene), Mark Girardi (Boston Healthcare), Wen Huang (Vela Diagnostics)
Organizers: Hui Xu and Wen Huang
Date: 2019-12-10
Time: 8:45-17:00 Pacific Time
Registration fee: (USD):
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (1)Crown Bio;(Major Sponsorship - afternoon session still open)
Vendor show vendors registered to date: (2)PHC former Panasonic Healthcare; Viitai
Registration deadline:2019-12-08  (it will close sooner if the seating cap is reached)

About the Topic

Precision medicine aims to tailor disease prevention and treatment considering differences in individual's genes, environments, and lifestyles. This symposium will review the progress in this field that enable clinicians to quickly, efficiently and accurately predict the most appropriate course of action for a patient and help drug developers to select the right patients for the clinical trials to maximize the probability of clinical success.



Section 1: Technologies

Section 2: Applications

Section 3: Commercialization fo IVD Products

8:45 - 9:00  PBSS Welcome Remarks

9:00 - 9:20  Introduction and field overview (Hui Xu, CPO, InterVenn Biosciences) 

9:20 - 10:05  Multi-cancer detection of early-stage cancers with simultaneous tissue localization using a plasma cfDNA-based targeted methylation assay (Eric Fung, Senior Group Medical Director, GRAIL)

10:05 - 10:15  major Sponsor's presentation - Crown Bioscience

10:15 10:30  Coffee break

10:30 to 11:15 The opportunities and challenges of Metabolomics biomarkers discovery and development in clinical diagnostics (Hua-Fen Liu, CEO, Calibra Diagnostics)

11:15-12:00  Proteomics and Glycoproteomics for Diagnostics (Sharon Pitteri, Associate Professor Of Radiology (Cancer Early Detection-Canary Center), Stanford University)

12:00-1:00  Lunch break

1:00-1:45  Overcoming limitations of next generation sequencing using functional profiling (Chris Apfel, CEO, Sage Medic)

1:45-2:30  Infectious disease applications (Sean Zhang, Associate Professor of Pathology, Johns Hopkins University)

2:30-2:45  Coffee break

2:45-3:15  CDx for clinical trials and drug development (Kunbin Qu, Director of Cancer Genomics, Beigene)

3:15-4:00  Companion Diagnostics in Immuno-Oncology: Global Commercial and Partnership Considerations (Mark Girardi, SVP, Boston Healthcare)

4:00-4:45  A journey to comercial launch of FDA approved IVD products from an IVD Start-up (Wen Huang, CTO & Head of Early Research (Global), Vela Diagnostics)

4:45-5:15  Q&A session and closing remarks

2020-09-17, Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
2020-10-19, [New Date] Preclinical and Clinical Development of Cell-based Immunotherapies: Translational PKPD, Safety, Biomarker, CMC, Clinical Pharmacology & Clinical Trials
2021-07-29, Development of Inhalation Therapeutics (a joint symposium by AAPS-BADGE / PBSS / Genentech)
┬ęPharmaceutical & BioScience Society, International; Last Modified: 7/5/2020; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
Hypha Discovery Ltd. Experts in scalable synthesis & purification of drug metabolites, including CYP, AOX, FMO metabolites as well as O-, N-, acyl glucuronides & sulfates.
Submit a Text Ad